TELA Bio, Inc. (TELA) CEO Tony Koblish on Q4 2021 Results - Earnings Call Transcript

Mar. 21, 2022 9:30 PM ETTELA Bio, Inc. (TELA) Stock1 Comment
SA Transcripts profile picture
SA Transcripts
150.91K Followers

Q4: 2022-03-21 Earnings Summary

10-K10-Q
EPS of -$0.59 misses by $0.04 | Revenue of $8.37M (47.77% Y/Y) beats by $405.25K

TELA Bio, Inc. (NASDAQ:TELA) Q4 2021 Earnings Conference Call March 21, 2022 4:30 PM ET

Company Participants

Louisa Smith - Investor Relations
Tony Koblish - President and Chief Executive Officer
Roberto Cuca - Chief Operating Officer and Chief Financial Officer

Conference Call Participants

Drew Stafford - Piper Sandler
Kyle Rose - Canaccord
Zach Weiner - Jefferies
Dave Turkaly - JMP Securities

Operator

Good afternoon, ladies and gentlemen and welcome to the TELA Bio Fourth Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Louisa Smith from the Gilmartin Group. You may begin.

Louisa Smith

Thank you, Towanda and good afternoon everyone. Earlier today, TELA Bio released financial results for the fourth quarter and full year 2021. A copy of the press release is available on the company’s website. Joining me on today’s call are Tony Koblish, President and Chief Executive Officer and Roberto Cuca, Chief Operating Officer and Chief Financial Officer.

Before we begin, I’d like to remind you that during this conference call, the company will make projections and forward-looking statements regarding future events. We encourage you to review the company’s past and future filings with the SEC including, without limitation, the company’s 2020 Form 10-K and subsequent Form 10-Qs, which identify the specific factors that may cause actual results or events to differ materially from those described in these forward-looking statements. These factors may include, without limitation, statements regarding product development, product potential, the impact of COVID-19, the regulatory environment, sales and marketing strategies, capital resources or operating performance.

With that, I will now turn the call over to Tony.

Tony Koblish

Thank you, Louisa and good afternoon everyone. Thanks for joining us today. I am pleased to report that TELA Bio finished the year

Recommended For You

About TELA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on TELA